Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Rang in Aktien #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Aktienkurs
$0.2219522
Zuletzt synchronisiert: 2025-09-11
Marktkapitalisierung
$1.10B
Veränderung (1 Tag)
0.04%
Veränderung (1 Jahr)
0.17%
Land
CN
Handel Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Aktien-Split-Historie für Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Die Aktie Hubei Biocause Pharmaceutical Co., Ltd. (Symbol: 000627) durchlief insgesamt 8 Aktiensplits.
Der letzte Aktiensplit fand am Apr 12, 2010 statt.
Eine 000627-Aktie, die vor dem Dec 27, 1996 gekauft wurde, entspricht heute 21.70959235632 000627-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
2010-04-12 37:20 x1.85 x21.70959235632
2005-11-09 33:25 x1.32 x11.7349147872
2002-06-12 23:20 x1.15 x8.89008696
2001-09-24 3:2 x1.5 x7.7305104
2001-05-23 59649:50000 x1.19298 x5.1536736
2000-05-16 6:5 x1.2 x4.32
1999-09-07 9:5 x1.8 x3.6
1996-12-27 2:1 x2 x2
Aktiensplits ähnlicher Unternehmen oder Wettbewerber